PA8571501A1 - Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa - Google Patents
Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasaInfo
- Publication number
- PA8571501A1 PA8571501A1 PA20038571501A PA8571501A PA8571501A1 PA 8571501 A1 PA8571501 A1 PA 8571501A1 PA 20038571501 A PA20038571501 A PA 20038571501A PA 8571501 A PA8571501 A PA 8571501A PA 8571501 A1 PA8571501 A1 PA 8571501A1
- Authority
- PA
- Panama
- Prior art keywords
- triariloxiariloxipirimidin
- metaloproteinase
- inhibitors
- trion
- triona
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
LA PRESENTE INVENCION SE REFIERE A INHIBIDORES TRIARILOXIARILOXIPIRIMIDIN-2,4,6-TRIONA DE METALOPROTEINASA DE FORMULA I EN LA QUE X, A, Y, B, G, W Y R1 SON COMO SE DEFINEN EN LA MEMORIA DESCRIPTIVA, Y A COMPOSICIONES FARMACEUTICAS Y PROCEDIMIENTOS DE TRATAMIENTO DE LA INFLAMACION, EL CANCER Y OTROS TRASTORNOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37599002P | 2002-04-26 | 2002-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8571501A1 true PA8571501A1 (es) | 2003-12-10 |
Family
ID=29270744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20038571501A PA8571501A1 (es) | 2002-04-26 | 2003-04-22 | Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa |
Country Status (18)
Country | Link |
---|---|
US (1) | US7119201B2 (es) |
EP (1) | EP1501515B1 (es) |
JP (1) | JP2005529132A (es) |
AR (1) | AR039658A1 (es) |
AT (1) | ATE308325T1 (es) |
AU (1) | AU2003216677A1 (es) |
BR (1) | BR0309386A (es) |
CA (1) | CA2484067A1 (es) |
DE (1) | DE60302149T2 (es) |
DO (1) | DOP2003000621A (es) |
ES (1) | ES2250880T3 (es) |
GT (1) | GT200300082A (es) |
MX (1) | MXPA04009392A (es) |
NI (1) | NI200300045A (es) |
PA (1) | PA8571501A1 (es) |
TW (1) | TW200403998A (es) |
UY (1) | UY27772A1 (es) |
WO (1) | WO2003090752A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005527598A (ja) | 2002-04-26 | 2005-09-15 | ファイザー・プロダクツ・インク | トリアリール−オキシ−アリール−スピロ−ピリミジン−2,4,6−トリオンメタロプロテイナーゼ阻害剤 |
DE60302150D1 (en) * | 2002-04-26 | 2005-12-08 | Pfizer Prod Inc | N-substituiete heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trion metalloproteinase inhibitoren |
JP2005529889A (ja) * | 2002-04-26 | 2005-10-06 | ファイザー・プロダクツ・インク | ピリミジン−2,4,6−トリオンメタロ−プロテイナーゼ阻害剤 |
NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
PL1750862T3 (pl) | 2004-06-04 | 2011-06-30 | Teva Pharma | Kompozycja farmaceutyczna zawierająca irbesartan |
US8710038B2 (en) * | 2004-09-17 | 2014-04-29 | Exelixis, Inc. | Pyrazole kinase modulators and methods of use |
US9045442B2 (en) | 2007-12-21 | 2015-06-02 | University Of Notre Dame Du Lac | Antibacterial compounds and methods of using same |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
GB201115937D0 (en) | 2011-09-14 | 2011-10-26 | Univ Aberdeen | 18F-labelled compounds for use as positron emission imaging agents |
EP3104861A4 (en) * | 2014-02-14 | 2017-10-04 | Warrell, Raymond P., Jr. | Bifunctional compounds and use for reducing uric acid levels |
WO2015127378A1 (en) | 2014-02-21 | 2015-08-27 | Medicomp Systems, Inc. | Intelligent prompting of protocols |
KR20170113529A (ko) | 2014-09-25 | 2017-10-12 | 유니버시티 오브 노트르 담 듀락 | 비-베타 락탐 항생제 |
JP2018502896A (ja) | 2015-01-22 | 2018-02-01 | ピー.,ジュニア ワーレル,レイモンド | 二機能性化合物および尿酸レベルを低下させるための使用 |
TWI771303B (zh) | 2016-06-30 | 2022-07-21 | 美商艾克奎斯特有限責任公司 | 化合物及其於降低尿酸位準之用途(一) |
CN109476642B (zh) | 2016-07-06 | 2022-01-25 | 阿奎斯特有限责任公司 | 化合物及其用于降低尿酸水平的用途 |
WO2018049404A1 (en) | 2016-09-12 | 2018-03-15 | University Of Notre Dame Du Lac | Compounds for the treatment of clostridium difficile infection |
LT3700902T (lt) | 2017-10-27 | 2023-06-26 | Boehringer Ingelheim International Gmbh | Trpc6 inhibitoriai |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
DE19548624A1 (de) * | 1995-12-23 | 1997-06-26 | Boehringer Mannheim Gmbh | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE69831233T2 (de) * | 1997-06-21 | 2006-06-01 | Roche Diagnostics Gmbh | Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung |
US6265578B1 (en) * | 1999-02-12 | 2001-07-24 | Hoffmann-La Roche Inc. | Pyrimidine-2,4,6-triones |
PA8498701A1 (es) * | 1999-08-12 | 2002-08-26 | Pfizer Prod Inc | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas |
EA200300409A1 (ru) * | 2000-10-26 | 2003-08-28 | Пфайзер Продактс Инк. | Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназы |
US6841671B2 (en) | 2000-10-26 | 2005-01-11 | Pfizer Inc. | Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
JP2005527598A (ja) | 2002-04-26 | 2005-09-15 | ファイザー・プロダクツ・インク | トリアリール−オキシ−アリール−スピロ−ピリミジン−2,4,6−トリオンメタロプロテイナーゼ阻害剤 |
DE60302150D1 (en) | 2002-04-26 | 2005-12-08 | Pfizer Prod Inc | N-substituiete heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trion metalloproteinase inhibitoren |
-
2003
- 2003-03-07 NI NI200300045A patent/NI200300045A/es unknown
- 2003-04-01 DO DO2003000621A patent/DOP2003000621A/es unknown
- 2003-04-10 GT GT200300082A patent/GT200300082A/es unknown
- 2003-04-15 EP EP03712588A patent/EP1501515B1/en not_active Expired - Lifetime
- 2003-04-15 AU AU2003216677A patent/AU2003216677A1/en not_active Abandoned
- 2003-04-15 AT AT03712588T patent/ATE308325T1/de not_active IP Right Cessation
- 2003-04-15 MX MXPA04009392A patent/MXPA04009392A/es unknown
- 2003-04-15 JP JP2003587386A patent/JP2005529132A/ja active Pending
- 2003-04-15 CA CA002484067A patent/CA2484067A1/en not_active Abandoned
- 2003-04-15 WO PCT/IB2003/001560 patent/WO2003090752A1/en active IP Right Grant
- 2003-04-15 DE DE60302149T patent/DE60302149T2/de not_active Expired - Fee Related
- 2003-04-15 ES ES03712588T patent/ES2250880T3/es not_active Expired - Lifetime
- 2003-04-15 BR BR0309386-7A patent/BR0309386A/pt not_active IP Right Cessation
- 2003-04-22 PA PA20038571501A patent/PA8571501A1/es unknown
- 2003-04-23 UY UY27772A patent/UY27772A1/es not_active Application Discontinuation
- 2003-04-24 AR ARP030101419A patent/AR039658A1/es unknown
- 2003-04-25 TW TW092109776A patent/TW200403998A/zh unknown
- 2003-04-28 US US10/424,614 patent/US7119201B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2484067A1 (en) | 2003-11-06 |
DE60302149D1 (de) | 2005-12-08 |
JP2005529132A (ja) | 2005-09-29 |
TW200403998A (en) | 2004-03-16 |
WO2003090752A1 (en) | 2003-11-06 |
DE60302149T2 (de) | 2006-07-20 |
DOP2003000621A (es) | 2003-10-31 |
US20040006057A1 (en) | 2004-01-08 |
AR039658A1 (es) | 2005-03-02 |
AU2003216677A1 (en) | 2003-11-10 |
UY27772A1 (es) | 2003-11-28 |
EP1501515B1 (en) | 2005-11-02 |
ATE308325T1 (de) | 2005-11-15 |
BR0309386A (pt) | 2005-02-22 |
ES2250880T3 (es) | 2006-04-16 |
EP1501515A1 (en) | 2005-02-02 |
NI200300045A (es) | 2005-07-08 |
US7119201B2 (en) | 2006-10-10 |
MXPA04009392A (es) | 2005-01-25 |
GT200300082A (es) | 2004-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8572101A1 (es) | Inhibidores de metaloproteinasa de aril-heteroariloxi-ariloxi-pirimidina-2,4,6-triona | |
PA8531501A1 (es) | Inhibidores de metaloproteinasa del tipo pirimidin-2,4,6-triona | |
PA8571501A1 (es) | Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa | |
PA8572701A1 (es) | Inhibidores de metaloproteinasa de heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida | |
UY26285A1 (es) | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
PA8572201A1 (es) | Inhibidores de metaloproteinasa de triaril-oxi-aril-espiro-pirimidina-2,4,6-triona | |
PE20081506A1 (es) | Formulaciones de ansamicina | |
TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
MXPA05013977A (es) | Metodos y composiciones para tratar enfermedades relacionadas con amiloide. | |
TR200102020T2 (tr) | Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler. | |
BRPI0409367A (pt) | derivados de piperidina inibidores de renina | |
HRP20070552T3 (en) | Combination of mglur2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders | |
CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
DE60239218D1 (de) | Synergistische zusammensetzungen für die behandlung von saatgut | |
AR045016A1 (es) | Derivados de 5-carbamimidoi-2-metilsulfaniltiofen-3-sulfonil como inhibidores conjugados de la cascada de complemento y su uso en el tratamiento de enfermedades. | |
NO20054494L (no) | Peptidvektorer | |
DE60312211D1 (de) | Haarbehandlungsmittel | |
ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
UY28247A1 (es) | Compuestos de benzopirano para uso en el tratamiento y la prevención de afecciones relacionadas con la inflamación. | |
CY1116137T1 (el) | Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας | |
RS50523B (sr) | Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze | |
MX2007001123A (es) | Metodo con mezcla agricola conteniendo un agente generador de oxido nitrico. | |
PA8579401A1 (es) | Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b | |
BRPI0414423A (pt) | inibidores de pace4, suas composições farmacêuticas e respectivos usos |